Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazineRAFFO, Anthony; HANCOCK, Kolbe; FREEBY, Matthew et al.Journal of endocrinology. 2008, Vol 198, Num 1, pp 41-49, issn 0022-0795, 9 p.Article

Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cellsADAMSON, C. R; EMLEY, T. E; HERBIG, L. J et al.Neurochemistry international. 1997, Vol 30, Num 4-5, pp 411-415, issn 0197-0186Article

Tardive Dyskinesia Caused by TetrabenazineLEWITT, Peter A.Clinical neuropharmacology. 2013, Vol 36, Num 3, pp 92-93, issn 0362-5664, 2 p.Article

Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiaprideKOCH, H. J; SZECSEY, A; VOGEL, M et al.International journal of clinical practice (Esher). 2003, Vol 57, Num 2, pp 147-149, issn 1368-5031, 3 p.Article

Tetrabenazine treatment for tardive dyskinesia : Assessment by randomized videotape protocolONDO, W. G; HANNA, P. A; JANKOVIC, J et al.The American journal of psychiatry. 1999, Vol 156, Num 8, pp 1279-1281, issn 0002-953XArticle

Long-term effects of tetrabenazine in hyperkinetic movement disordersJANKOVIC, J; BEACH, J.Neurology. 1997, Vol 48, Num 2, pp 358-362, issn 0028-3878Conference Paper

Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administrationKURIBARA, H.Pharmacology, biochemistry and behavior. 1997, Vol 56, Num 1, pp 9-14, issn 0091-3057Article

Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up studyKIMIAGAR, Itzhak; DOBRONEVSKY, Evgenia; PROKHOROV, Tatiana et al.Journal of neurology. 2012, Vol 259, Num 4, pp 660-664, issn 0340-5354, 5 p.Article

Tetrabenazine Augmentation in Treatment-Resistant Schizophrenia: A 12-Week, Double-Blind, Placebo-Controlled TrialREMINGTON, Gary; KAPUR, Shitij; FOUSSIAS, George et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 1, pp 95-99, issn 0271-0749, 5 p.Article

Tardive Dyskinesia and Other Movement Disorders Secondary to AripiprazoleSIERRA PENA, Maria; YALTHO, Toby C; JANKOVIC, Joseph et al.Movement disorders. 2011, Vol 26, Num 1, pp 147-152, issn 0885-3185, 6 p.Article

Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2FANG ZHENG; GUANGRONG ZHENG; GABRIELA DEACIUC, A et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 8, pp 2975-2992, issn 0968-0896, 18 p.Article

Tetrabenazine as antichorea therapy in Huntington disease : A randomized controlled trialNeurology. 2006, Vol 66, Num 3, pp 366-372, issn 0028-3878, 7 p.Article

Tetrabenazine therapy of pediatric hyperkinetic movement disordersJAIN, Samay; GREENE, Paul E; FRUCHT, Steven J et al.Movement disorders. 2006, Vol 21, Num 11, pp 1966-1972, issn 0885-3185, 7 p.Article

Repetitive administration of tetrabenazine induces irreversible changes in locomotion and morphology of the substantia nigra in ratsSATOU, Takao; ANDERSON, Aileen J; ITOH, Tatsuki et al.Experimental and toxicologic pathology (Print). 2001, Vol 53, Num 4, pp 303-308, issn 0940-2993Article

Tetrabenazine Treatment for Stereotypies and Tics Associated With DementiaONDO, William G.The Journal of neuropsychiatry and clinical neurosciences. 2012, Vol 24, Num 2, pp 208-214, issn 0895-0172, 7 p.Article

In vivo and in vitro characterization of [¹⁸F]-FE-(+)-DTBZ as a tracer for beta-cell massERIKSSON, Olof; JAHAN, Mahabuba; JOHNSTRÖM, Peter et al.Nuclear medicine and biology. 2010, Vol 37, Num 3, pp 357-363, issn 0969-8051, 7 p.Article

Role of Tetrabenazine for Huntington's Disease-Associated ChoreaPOON, Linda H; KANG, Gail A; LEE, Audrey J et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 6, pp 1080-1089, issn 1060-0280, 10 p.Article

Tetrabénazine pour traiter la chorée de Huntington = Tetrabenazine (Xenazine) for Huntington's ChoreaThe Medical letter on drugs and therapeutics (Edition française). 2009, Vol 31, Num 4, pp 15-16, issn 0253-8512, 2 p.Article

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disordersKENNEY, Christopher; HUNTER, Christine; JANKOVIC, Joseph et al.Movement disorders. 2007, Vol 22, Num 2, pp 193-197, issn 0885-3185, 5 p.Article

Traitement des mouvements anormaux hyperkinétiques par la tétrabénazine : le retour.. = Treatment of hyperkinetic movement disorders: tetrabenazine is back..DERKINDEREN, P; BROUSSOLLE, E; BURBAUD, P et al.La Lettre du neurologue. 2007, Vol 11, Num 5, pp 176-178, issn 1276-9339, 3 p.Article

Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismusSITBURANA, Oraporn; ONDO, William G.Movement disorders. 2006, Vol 21, Num 11, pp 2023-2025, issn 0885-3185, 3 p.Article

A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatmentPETZINGER, G. M; BRESSMAN, S. B.Movement disorders. 1997, Vol 12, Num 2, pp 246-248, issn 0885-3185Conference Paper

Successful Use of Tetrabenazine in a Patient with Intractable Hiccups After StrokeNARO, Antonino; BRAMANTI, Placido; CALABRO, Rocco Salvatore et al.Pharmacotherapy. 2014, Vol 34, Num 12, issn 0277-0008, p. 1356Article

Tetrabenazine: For Chorea Associated with Huntington's DiseaseSCOTT, Lesley J.CNS drugs. 2011, Vol 25, Num 12, pp 1073-1085, issn 1172-7047, 13 p.Article

Dramatic Response of Facial Stereotype/Tic to Tetrabenazine in the First Reported Cases of Neuroferritinopathy in the United StatesONDO, William G; ADAM, Octavian R; JANKOVIC, Joseph et al.Movement disorders. 2010, Vol 25, Num 14, pp 2470-2472, issn 0885-3185, 3 p.Article